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Human data on protein binding and dose-dependent changes in toxicokinetics for MCPA are very lim-
ited. 128 blood samples were obtained in 49 patients with acute MCPA poisoning and total and unbound
concentrations ofMCPAwere determined. The Scatchard plot was biphasic suggesting protein binding to
two sites. The free MCPA concentration increased when the total concentration exceeded 239mg/L (95%
conﬁdence interval 198–274mg/L). Nonlinear regression using a two-site binding hyperbola model esti-
mated saturation of the high afﬁnity binding site at 115mg/L (95%CI 0–304). Further analyses using global
ﬁtting of serial data and adjusting for the concentration of albumin predicted similar concentrations for-Chloro-2-methylphenoxyacetic acid
MCPA)
oxicokinetic
rotein binding
ose-dependent
saturable binding (184mg/L and 167mg/L, respectively) without narrowing the 95%CI. In 25 patients, the
plasma concentration–time curves for both bound and unbound MCPA were approximately log-linear
which may suggest ﬁrst order elimination, although sampling was infrequent so zero order elimination
cannot be excluded. Using a cut-off concentration of 200mg/L, the half-life of MCPA at higher concen-
trations was 25.5h (95%CI 15.0–83.0h; n=16 patients) compared to 16.8h (95%CI 13.6–22.2h; n=10
patients) at lower concentrations. MCPA is subject to saturable protein binding but the inﬂuence on
l.half-life appears margina
. Introduction
The chlorophenoxy compounds 4-chloro-2-
ethylphenoxyacetic acid (MCPA) and 2,4-dichlorophenoxyacetic
cid (2,4-D) are selective herbicides used in agricultural and
ousehold sectors worldwide. 2,4-D is the most commonly used
hlorophenoxy herbicide in the US (Kiely et al., 2004) and acute
Abbreviations: MCPA, 4-chloro-2-methylphenoxyacetic acid; 2,4-D, 2,4-
ichlorophenoxyacetic acid; t1/2, apparent elimination half-life; Cu, free (unbound)
lasma concentration; Kdi , afﬁnity constant of binding at the ith site; Bmaxi , max-
mum density (concentration of saturation) of binding at the ith site; Ci , initial
oncentration; Ct , concentration after time t; k, elimination rate constant; LOD,
imit of detection; LOR, limit of reporting; Tmax, time of the maximum plasma con-
entration; IQR, interquartile range; Koc, octanol solubility coefﬁcient; pKa, acid
issociation constant; CL, clearance; Vd, volume of distribution.
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self-poisoning with MCPA is a common reason for presentation to
rural hospitals in Sri Lanka where subsistence farming is common
(Roberts et al., 2005). Severe poisoning including coma, rhab-
domyolysis and renal toxicitymay occur and persist for some days.
Death occurs in around 5% of patients and is typically 24–48h post-
ingestion (Roberts et al., 2005). Themechanism of fatal toxicity has
not been deﬁned (Roberts et al., 2005). Animal studies have also
suggested that prolonged elimination of chlorophenoxy herbicides
leads to increased toxicity (Timchalk, 2004). Further, saturation
of protein binding increases the free (unbound) concentration of
the poison, which is then available to distribute from the plasma
(central) compartment. In the case of chlorophenoxy compounds,
this is important because the mechanism of toxicity is thought to
relate to disruption of intracellular processes (Roberts and Buckley,
2007a).
The treatment of acute chlorophenoxy herbicide poisoning con-
Open access under CC BY license.sists of decontamination of the gastrointestinal tract, resuscitation
and supportive care. Treatments that increase herbicide clear-
ance have been proposed including urinary alkalinisation (which
increases renal clearance by ‘ion-trapping’) and haemodialysis
(Bradberry et al., 2004). The toxicokinetics of the chlorophenoxy
D.M. Roberts et al. / Toxicology Le
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oig. 1. Semi-logarithmic plasmaMCPA concentration–time using data from the lit-
rature: a case report of acute self-poisoning (Schmoldt et al., 1997) and a low-dose
olunteer study (Kolmodin-Hedman et al., 1983).
erbicides must be known to determine or interpret the effect of
uch interventions.
Animal studies of acute chlorophenoxy exposures demonstrate
on-linear kinetics with high exposures due to dose-dependent
hanges in distribution and clearance for all herbicides within
his group (Arnold and Beasley, 1989). MCPA is subject to dose-
ependent saturation of protein binding in vitro (Roberts and
uckley, 2007a). While there is a prolonged apparent elimina-
ion half-life (t1/2) in animals with larger exposures it is unclear
f this reﬂects decreased clearance or increased volume of distri-
ution and whether the total and free concentrations are moving
n tandem (Arnold and Beasley, 1989; Roberts and Buckley, 2007a;
oberts et al., 2005). It is necessary to better understand the dose-
ependent kinetics in order to interpret changes after treatments
hat aim to increase clearance.
Only two publications have described the kinetics of MCPA
n humans, one was a single case of intentional self-poisoning
Schmoldt et al., 1997) and the other was a low-dose volunteer
tudy (Kolmodin-Hedman et al., 1983). Comparison of the apparent
limination t1/2 fromthese reportsmay indicate thatMCPAexhibits
ose-dependent elimination (Fig. 1). The authors of this case report
ttributed thedecrease in apparent half-life to treatmentwith alka-
ine diuresis (Schmoldt et al., 1997). However, a change in clearance
asnot directly quantiﬁed anddose-dependent changes in kinetics
ay explain the proﬁle observed.
Details on the kinetics of MCPA are, therefore, of interest to
uide research into the clinical management of acute poisoning.
n particular, if the elimination of MCPA is conﬁrmed to be pro-
onged inacutepoisoning thiswill support research into treatments
hat enhance elimination. If the unbound concentrations are high
his would indicate that haemodialysis might be effective. Here,
e describe the plasma kinetics of MCPA in patients with acute
ntentional self-poisoning.
. Materials and methods
.1. ClinicalThis is an observational study. Patients were identiﬁed by on-site study doc-
ors on presentation to Anuradhapura or Polonnaruwa Hospitals with a history of
cute poisoning. These hospitals provide 24-hmedical and nursing care to patients.
atientswere regularly reviewedand clinical detailswere recordedprospectively by
n-site study doctors until discharge or death. All patients received supportive caretters 201 (2011) 270–276 271
which included supplemental oxygen, intravenous ﬂuids, ventilatory and haemody-
namic support as required. Antibiotics (usually penicillin and metronidazole) were
given when aspiration pneumonitis was suspected clinically. There were no treat-
ments involving urinary alkalinisation or haemodialysis due to resource limitations
in the region.
Written informed consent was obtained in all patients who participated in this
study. An admission blood samplewas provided by patients followed by serial sam-
ples at 1, 4, 12, and 24h, then once daily until discharge or death, as allowed by
clinical factors. Blood was collected into an EDTA tube which was promptly cen-
trifuged and the plasmawas removed and frozen at−23 ◦C until the time of analysis.
Ethics approval for this observational study was obtained from Sri Lanka (the
Universities of Colombo, Peradeniya and Sri Lankan Medical Association) and the
grantholder’s universities (Oxfordshire Clinical Research Ethics Committee (UK) and
Australian National University).
2.2. Laboratory
The total and free (unbound) concentrations of MCPA were quantiﬁed in the
samples collected above in addition to admission samples collected for a previous
study (Roberts et al., 2005). The total MCPA concentration was measured in the
above-mentioned plasma samples. 300L of plasma was then ultraﬁltered using
Millipore Centrifree Micropartition Device® (Millipore, Bedford, MA, USA) yield-
ing approximately 100g of plasma ultraﬁltrate. The concentration of MCPA in the
ultraﬁltrate is the free (unbound) concentration.
The concentrations of MCPA were determined by Queensland Health Scientiﬁc
Services (Australia) using a method derived from that of the United States Envi-
ronmental Protection Agency (EPA, 1980). 100g of plasma or ultraﬁltrate was
hydrolysed in diluted sodiumhydroxide and thenbufferedwith acetic acid. The con-
centration of MCPA was determined by HPLC–MS/MS using an AB/Sciex API4000Q
mass spectrometer in the negative ion mode equipped with an electrospray (Tur-
boV) interface. Thiswas coupled to a Shimadzu ProminenceHPLC system (Shimadzu
Corp., Kyoto, Japan) and a 50mm×2mm C6-phenyl column (Phenomenex, Tor-
rance, CA). The limit of reporting for the LCMSMSmethod was 1g/L for MCPA and
the method was linear from at least 1–300g/L.
Method recovery was conﬁrmed using MPCA concentrations of 2.5mg/L to
around 300mg/L with an average recovery of 105% and a standard deviation 0.25.
Therefore, the limit of detection (LOD; 3× standard deviation) is 0.75mg/kg and the
limit of reporting (LOR; using 6× LOD) is 4.5mg/kg. The resulting concentrations
(mg/kg plasma) were multiplied by 1.0205 which is the speciﬁc gravity of plasma
at 37 ◦C (Trudnowski and Rico, 1974) to allow reporting with the unit mg/L.
To validate the Centrifree® ultraﬁltration device, plasma from a patient with
MCPA poisoning was ultraﬁltered, analysed for MCPA, re-ultraﬁltered and then re-
analysed forMCPA. There was no change in the concentration of MCPA between the
2 ultraﬁltrates soMCPA does not appear to be adsorbed to the ultraﬁltration device.
Further, control plasmawhichdidnot containMCPAwasultraﬁlteredand theﬁltrate
was analysed for protein. It was noted that <0.2% of protein remained, suggesting
that the Centrifree® ultraﬁltration device was efﬁcient for removing protein from
plasma samples.
The albumin concentration was determined in all admission samples and the
concentration of albumin and creatininewas determined in all serial samples. These
analyses were conducted by Queensland Health Forensic and Scientiﬁc Services at
Princess Alexandra Hospital, Brisbane, Australia. This service is accredited by the
National Association of Testing Authorities, Australia and certiﬁed to International
Standards (ISO 9001).
3. Calculations
The MCPA concentration–time proﬁle in patients providing
the most serial samples was constructed using the total and free
MCPA concentrations. A plot of the free versus total MCPA con-
centration was then constructed using data from all admission
and serial plasma samples to determine whether protein binding
was saturable and the approximate concentration at which this
occurred.
The bound MCPA concentration was calculated as the differ-
ence between the free and total concentration at each time point.
A Scatchard plot was constructed using the bound and free MCPA
concentrations to estimate the number of apparent protein bind-
ing sites. Here, following visual inspection, a one-phase (linear)
relationship suggests one-site binding, a two-phase relationship
suggests two-site binding, and so on (Kermode, 1989; Molinoff
et al., 1981; Motulsky and Christopoulos, 2005). In the case of
two-site binding the relationship between free and bound con-
centrations is quantiﬁed by nonlinear regression using a two-site
2 logy Letters 201 (2011) 270–276
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Table 1
Demographic and baseline data for 25 patients in whom multiple blood samples
were obtained. Results shown as median and interquartile range.
Age (years) 25.5 (21.3–27.8)
Gender (M:F) 18:7
Time to present (h) 3.3 (2.5–6.0)
Duration of sampling (h) 40.8 (27.3–50.1)72 D.M. Roberts et al. / Toxico
inding hyperbola model as follows:
ound concentration = Bmax1 ·
Cu
Kd1 + Cu
+ Bmax2 ·
Cu
Kd2 + Cu
Here, Cu is the free (unbound) plasma concentration of MCPA
nd Kdi and Bmaxi are the afﬁnity constant and maximum density
concentration of saturation) of binding at the ith site (Molinoff
t al., 1981; Motulsky and Christopoulos, 2005). This analysis was
nitially conducted using the combinedpopulation data. To account
or possible inter-individual variability in protein binding, the
nalysis was also conducted by global ﬁtting. Global ﬁtting is a
omputational regressionmethodwhich incorporates best-ﬁt data
or individuals when determining the best-ﬁt data for the group
s a whole. Finally, because chlorophenoxy compounds largely
ind to albumin (Braunlich et al., 1989; Rosso et al., 1998), this
egressionwas also conducted relative to the concentrationof albu-
in (g/L) to determine the extent to which this inﬂuenced the
t. When determining the protein binding properties of MCPA
t was assumed that binding was at equilibrium at the time of
easurement.
To determine whether saturation of protein binding inﬂuences
learance in humans the plasma apparent elimination half-life
as determined prior to and following the concentration where
aturation was calculated to occur. Data from patients provid-
ng two or more samples above or below the concentration of
aturation were included and the best-ﬁt apparent elimination
alf-life and 95% conﬁdence interval was determined for the
ohort. This was performed by non-linear regression with global
tting of the rate constant in a monoexponential decay model
Ct =Ci × exp(−k · t)). Here, Ci is the initial concentration and Ct
s the concentration after time t when elimination occurs with
rate constant of k. In this analysis, Ct and Ci were allowed to
ary between individuals to account for differences in exposure.
atients in whom the concentrations were not greater than the
OR in at least two samples were excluded from the kinetic analy-
is.
All regressions were conducted using GraphPad Prism ver-
ion 4.03 for Windows, GraphPad Software, San Diego CA USA,
ww.graphpad.com.
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Fig. 2. Semi-logarithmic plasma MCPA concentration–tAdmission concentration (mg/L) 520 (186–654)
Outcomes (alive:death) 24:1
4. Results
Serial samples were obtained in 33 patients and in 25 of these
the concentrationswere greater than the limit of reporting (5mg/L)
allowing inclusion in the analyses. All patients presented following
acute intentional self poisoningand therewasonlyonedeath. In the
case of the survivors, regardless of the initial MCPA concentration,
all survivors demonstrated signs ofmild poisoning (predominantly
nausea, vomitingand/ormildabdominalpain) andweredischarged
from hospital within 24–48h (Table 1). The clinical sequelae of the
patient who died have been reported previously (patient 7 in Table
2 (Roberts et al., 2005)). Brieﬂy, this was a 45-year-old man with
an altered level of consciousnesswhodevelopedprogressive tachy-
cardia, tachypnoea, fever, haematuria anddied10hpost-admission
tohospital.His treatment included intravenousﬂuids, endotracheal
intubation and a single dose of sodium bicarbonate 25mmol.
For all patients except three, the time of the maximum plasma
concentration (Tmax)was noted on admission (Table 1). In the oth-
ers the Tmax was at 3.7h for two patients and 7h post-ingestion
in the third patient. This suggests that the absorption phase can be
prolonged.
The concentration–time proﬁles for 6 patients with the high-
est number of samples are shown in Fig. 2. The initial rapid
decrease in MCPA concentration in A4505 and A4546 possibly rep-
resents a distribution phase. An inﬂection in the semi-logarithmic
concentration–time proﬁle is observed in A162 and A225 produc-
ing a biphasic convex (downward-concave) curve (similar to that
noted in rat administeredhighdoses (Roberts andBuckley, 2007a)).
A biphasic convex elimination curve was not obvious in the other
patients, which may reﬂect the infrequent and short duration of
sampling. In general, the free concentrationmirrored the total con-
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Fig. 4. (a) Relationship between the total and free concentration of MCPA demon-ig. 3. TheMCPA and creatinine plasma concentration–timeproﬁle of a 45-year-old
an who died 60h post-ingestion.
entration suggesting rapid equilibration between free and bound
CPA. Both curves are approximately log-linear which may sug-
est ﬁrst-order elimination in this concentration range, however
ue to the limited frequency of sampling, zero order elimination
annot be excluded.
The plasma concentration–time proﬁle for the patient who
ied is shown in Fig. 3. It differed substantially to that of other
atients shown in Fig. 2. During the 22h post-ingestion the
otal and free MCPA concentrations did not decrease and the
ree concentration was the highest observed in this cohort. This
lasma proﬁle may occur when there is prolonged absorption,
xtensive distribution and/or impaired clearance. The admission
lbumin concentration in this patient was lower than that of
he population (24g/L compared with median 40g/L, interquar-
ile range (IQR) 36–42g/L; n=48) which would increase the free
CPA concentration and its distribution from the central com-
artment. Further, the plasma creatinine concentration in this
atient was higher than others at admission (270mol/L com-
ared with 95mol/L, IQR 83–116mol/L; n=43) and increased
ntil the timeof death (Fig. 3). Such renal dysfunctionwould impair
CPA clearance (in contrast, the creatinine concentration in other
atients ﬂuctuated slightly or decreasedduring admission, data not
hown).
Protein binding characteristicswere determined in 128 samples
fter excluding sampleswhere the free concentrationwas less than
he level of reporting. The free/total MCPA ratio increased when
he total concentration exceeded 239mg/L (95% conﬁdence inter-
al 198–274mg/L) which is consistent with saturation of protein
inding (Fig. 4a).
The Scatchard plot was approximately biphasic (in particular
hen the bound concentration was adjusted for the concentration
f albumin), suggesting protein binding to two sites of differing
fﬁnity (Fig. 4b).
Estimation of the characteristics of two-site protein binding
sing the aggregate population data suggested saturation of the
igh afﬁnity binding site at a plasma MCPA concentration of
15mg/L, but the 95% conﬁdence intervals of the best-ﬁt values
ere wide (Fig. 5a). Analysis by global ﬁtting suggested saturation
f the higher afﬁnity binding site at a plasma MCPA concen-
ration of 184mg/L but the 95% conﬁdence intervals were not
arkedly reduced (Fig. 5b). Analysis of the aggregate population
ata adjusted for the albumin concentration predicted saturation
f protein binding at an MCPA plasma concentration of 4.2mg/L
er 1 g/L of albumin in plasma (167mg/L using themedian albumin
oncentration). Using this technique therewas less scatter from the
ine of best-ﬁt and the 95% conﬁdence intervals were decreased for
econd binding site but not the ﬁrst (Fig. 5c).strating saturableproteinbinding. (b) Scatchardplot showingabiphasic relationship
which suggests binding of MCPA to two sites. Grey broken lines are freely drawn to
indicate the two phases observed on visual inspection.
The concentration–time curves for all patientswho survived are
shown in Fig. 6. Based on the data presented in Fig. 5a–c, the high
afﬁnity protein binding site is saturated at a MCPA concentration
less than 200mg/L with a relatively wide 95% conﬁdence inter-
val. Using a tentative cut-off of 200mg/L the apparent elimination
half-life of the total concentration of MCPA during the initial phase
(concentrations >200mg/L) was 25.5h (95% conﬁdence interval
15.0–83.0h; n=16 patients). The terminal apparent elimination
half-life at lower concentrations was shorter at 16.8h (95% con-
ﬁdence interval 13.6–22.2h; n=10 patients). Data from the patient
who died were not included in this analysis because a maximum
plasma concentration was not apparent and the proﬁle was atypi-
cal.
5. Discussion
This is the ﬁrst description of the toxicokinetics of MCPA in
a series of patients with intentional self-poisoning. MCPA dis-
plays two-site protein binding with saturation of the higher
afﬁnity binding site at a concentration less than 200mg/L.
This is within the concentration range typically observed in
patients with acute poisoning, which can exceed 1000mg/L (e.g.
Fig. 6). When the concentration of MCPA exceeds the point of
saturation, the free concentration increases rapidly and it is antic-
ipated that MCPA will more readily distribute from the central
compartment. The apparent elimination half-life at higher con-
centrations was 25.5h which is slightly prolonged compared
to the terminal phase of 16.8h although the 95% conﬁdence
274 D.M. Roberts et al. / Toxicology Letters 201 (2011) 270–276
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The chlorophenoxy herbicides MCPA and 2,4-D display simi-
ar kinetic properties (Arnold and Beasley, 1989; Timchalk, 2004).
ase reports of human self-poisoning have attributed a change
n the apparent elimination half life of chlorophenoxy herbicides
o treatment with urinary alkalinisation/diuresis (Flanagan et al.,
990; Friesen et al., 1990; Prescott et al., 1979; Schmoldt et al.,
997). On review of these cases it appears that the change in
he apparent elimination half-life occurred when the concentra-
ion was approximately 150–300mg/L, similar to Fig. 1. This is
imilar to the MCPA concentration where protein binding to the
igh afﬁnity site appeared to saturate in our study (Fig. 5a–c) and
lso in rat studies (Roberts and Buckley, 2007a). Therefore, it is
ossible that the change in the apparent elimination half-life in
ig. 1 may have related in-part to the concentration-dependent
hange in toxicokinetics observed in our patients and in rat stud-
es.
Regardless of the method employed, it is noted that the afﬁn-
ty of the ﬁrst binding site for MCPA is extremely high and that it
s saturated when the MCPA concentration is less than 200mg/L
Fig. 5a–c). This conﬁrms ex vivo studies that demonstrated the
mportance of albumin for MCPA–protein binding (Roberts and
uckley, 2007a). Given an albumin concentration of approximately
00M, if MCPA binds to albumin in a ratio of 1:1 then the binding
ites are expected to be saturated at a concentration of 120mg/L.
edidnothavesufﬁcienthighconcentrationsamples todetermine
onﬁdently if the second lower afﬁnity site is potentially saturable
ith large exposures.
The pKa of MCPA is 3.04, so the proportion of MCPA that is
onised (water soluble) decreases as the pH decreases (becomes
cidic). This is reﬂected in the octanol solubility coefﬁcient (Koc)
hich is a measure of lipophilicity. The Koc of MCPA is 1.0 at pH 6
ndhigher, but theKoc increases to 5.2 at pH5and then45.6 at pH4
25 ◦C) (SciFinder, 2010). In vitro studies have conﬁrmed enhanced
ytotoxicity of chlorophenoxy compounds in an acidic medium,
resumably due to an increase in cell penetration (Cabral et al.,
003). Therefore, urinary and potentially plasma alkalinisation in
atients is likely to decrease the rate and extent of distribution due
o ion-trapping.
Renal elimination is the most important route of clear-
nce for MCPA (Fjeldstad and Wannag, 1977; Kolmodin-Hedman
t al., 1983) but hepatic clearance may also contribute since
lucuronidated metabolites are detected in the urine (Kolmodin-
edman et al., 1983). MCPA is ﬁltered, secreted and reabsorbed in
he nephron and the extent of this varies between animal species,
otably the rat and dog (Timchalk, 2004). Renal clearance also
arieswith hydration due to changes in urine ﬂow (Proudfoot et al.,
004). With high MCPA exposures there is nonlinear renal clear-tters 201 (2011) 270–276 275
ance which may be due to saturation of active excretion (e.g., the
renal organic anion transporting polypeptide) or direct nephro-
toxicity (Koschier and Berndt, 1977; Pritchard et al., 1982; van
Ravenzwaay et al., 2004). Penicillin may decrease MCPA clearance
by competing for active secretion, as noted in rats (Braunlich et al.,
1989); this antibioticwas not administered to the patientwho died
in this series. Nephrotoxicity in acute MCPA poisoning has been
reportedpreviously (Roberts et al., 2005) andmayhave contributed
to the death of one of our patients given the progressive increase
in creatinine (Fig. 3) and the very long elimination half-life.
Interpretation of elimination half-life is complex because it is a
secondary kinetic parameter that depends on clearance (CL) and
volume of distribution (Vd) which are related by half-life (t1/2),
where t1/2 = 0.693 ·Vd/CL. Further, the true elimination half-life can
only be calculated once absorption and distribution are complete,
which is difﬁcult to determine following acute ingestion (hence
the term ‘apparent’ elimination half-life) (Roberts and Buckley,
2007a). Biphasic convex concentration–time curves are observed
in other poisonings which are susceptible to non-linear kinet-
ics (Roberts and Buckley, 2007a). It is worthwhile determining
physiological factors contributing to the biphasic convex plasma
concentration–time proﬁle because this may guide research into
kinetic interventions for acute chlorophenoxy poisoning. Possible
contributors include prolonged absorption, multi-compartmental
concentration and pH-dependent distribution, saturable clearance
or the inﬂuence of conjugated metabolites. This requires careful
collection of both plasma and urine samples because the inﬂuence
ofdose-dependent toxicityor inter-individual variability inkinetics
cannot be determined from plasma data alone.
Therefore, animal studies have demonstrated enhanced elimi-
nationof various chlorophenoxycompounds, includingMCPA,with
urinary alkalinisation (Braunlich et al., 1989; Hook et al., 1976).
However, a systematic review failed to conﬁrm the efﬁcacy of this
treatment in humans and it is not commonly used in countries
where chlorophenoxy herbicide poisonings are frequent (Roberts
and Buckley, 2007b). To conﬁrm the effect of treatments that are
proposed to increase the elimination of chlorophenoxy herbicides
in humans, direct measurements of clearance are needed. In the
case of urinary alkalinisation this requires measurement of the
amount of the herbicide excreted in the urine and the extent
to which this changes with pH. Of the limited number of cases
where direct urinarymeasurements were conducted, urinary alka-
linisation/diuresis appeared to be useful (Flanagan et al., 1990;
Prescott et al., 1979). More research is required to further quan-
tify the effects of urinary alkalinisation and to deﬁne the optimal
treatment strategy. In patients with acute or chronic renal fail-
ure, other treatment strategies such as haemodialysis should be
trialled.
6. Conclusions
MCPA exhibits dose-dependent protein binding within the
range of concentrations seen in poisoning and possibly this leads
to dose-dependence in other kinetic parameters. The full extent to
which this occurs is not apparent from plasma concentration–time
data only. Caremust be takenwhen interpreting changes in kinetics
(e.g. half-life) as a result of a treatment. More data on the kinetics
ofMCPA and other chlorophenoxy herbicides are needed, in partic-
ular mechanistic data determining if there is a signiﬁcant increase
in total clearance with haemodialysis or urinary alkalinisation.Conﬂict of interest statement
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